Skip to content

A Novel Telehealth- Home uroflowmetry device with internet of things-based system in Lower Urinary Tract Symptoms

A Novel Telehealth- Home uroflowmetry device with internet of things-based system in Lower Urinary Tract Symptoms

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260316009
Enrollment
70
Registered
2026-03-16
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

male diagnosed benign prostatic hyperplasia with lower urinary tract symptoms. Home-based uroflowmetry Home uroflowmetry Benign prostatic hyperplasia Lower urinary tract symptoms

Interventions

Office- or hospital-based uroflowmetry is a non-invasive, objective, and well-established diagnostic modality for the assessment of lower urinary tract function. It constitutes a fundamental component
Office/ Hospital uroflowmetry,Home Uroflowmetry

Sponsors

None listed

Eligibility

Sex/Gender
Male
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with lower urinary tract disorders. 2 Male patients aged 18 to 80 years. 3. Patients scheduled to undergo uroflowmetry assessment using a uroflowmeter should follow the instructions. 4. Patients living in Bangkok and suburban areas who are able to void at home for a consecutive period of three days.

Exclusion criteria

Exclusion criteria: 1. Patients without a clinical indication for uroflowmetry assessment. 2. Patients who decline to participate in the study. 3. Patients who are unable or unwilling to attend follow-up visits or to perform home-based uroflowmetry measurements.

Design outcomes

Primary

MeasureTime frame
Home voiding includes maximum flow rate, average flow rate, voided volume, flow time and number of voids within 3 days. at 12 months after end of the intervention Home uroflowmetry,Hospital voiding includes maximum flow rate, average flow rate, voided volume and flow time at 12 months after end of the intervention Hospital uroflowmetry

Secondary

MeasureTime frame
Satisfaction of use at 12 months after end of the intervention Patient report outcome using the questionnaire,Hospital voiding at the visiting Uroflowmetry

Countries

Thailand

Contacts

Public ContactChavalit Honglertsakul

Faculty of Medicine, Vajira hospital. Navamindradhiraj University

chavalit@nmu.ac.th0635369354

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026